<DOC>
	<DOC>NCT02071134</DOC>
	<brief_summary>The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS system in the treatment of Parkinson's disease.</brief_summary>
	<brief_title>Registry of Deep Brain Stimulation With the VERCISEâ„¢ System: Vercise DBS Registry</brief_title>
	<detailed_description>The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS system in the treatment of Parkinson's disease. Subjects' improvement in disease symptoms and overall Quality of life will be assessed during the study following DBS and compared with baseline.</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Meets criteria established in locally applicable Vercise System Direction for Use At least 18 years old Meets any contraindication in the Vercise System locally applicable Directions for Use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Deep brain stimulation</keyword>
	<keyword>Parkinson's disease</keyword>
	<keyword>Vercise</keyword>
</DOC>